Stage II Esophageal Cancer Terminated Phase 2 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0029703 (Stage II Esophageal Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01307956Panitumumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Advanced Esophageal or Gastroesophageal Junction CancerTreatment